Dana-Farber Cancer Institute
Boston, Massachusetts
Joyce Liu, MD, MPH is an Associate Professor of Medicine at Dana Farber Cancer Institute and Harvard Medical School. She is a medical oncologist specializing in the treatment of women with gynecologic malignancies and is the Associate Chief and Director of Clinical Research for the Division of Gynecologic Oncology at Dana Farber Cancer Institute. Dr. Liu received her medical degree from Harvard Medical School and subsequently completed her residency in Internal Medicine at Brigham and Women’s Hospital and her fellowship in Medical Oncology at Dana-Farber Cancer Institute. She also has a Master of Public Health from the Harvard School of Public Health. Dr. Liu’s research focuses on identifying and validating novel therapies and therapeutic combinations for gynecologic cancers. She has received grant support from the National Cancer Institute, the American Society of Clinical Oncology (ASCO), and the Ovarian Cancer Research Fund Alliance. She is the co-chair of the NRG Ovarian Cancer Subcommittee, a member of the NRG Developmental Therapeutics Committee, a member of the NCCN Ovarian Cancel Panel, and has served on several ASCO guideline committees.
AstraZeneca (Individual(s) Involved: Self): Advisory Board; Clovis Oncology (Individual(s) Involved: Self): Honorarium for Invited talk to Clovis, Other Financial or Material Support; Eisai (Individual(s) Involved: Self): Advisory Board; Genentech (Individual(s) Involved: Self): Advisory Board; GSK (Individual(s) Involved: Self): Advisory Board; Regeneron (Individual(s) Involved: Self): Advisory Board
Friday, April 29, 2022
2:45 PM – 4:30 PM
Friday, April 29, 2022
3:10 PM – 3:30 PM
Friday, April 29, 2022
3:30 PM – 4:00 PM
Friday, April 29, 2022
4:00 PM – 4:30 PM